Multiple sclerosis and sexual dysfunction: A need for further education and interdisciplinary care

Delaney, Kate; Donovan, Jayne

doi:10.3233/nre-172200

Cited by 39 publications

(22 citation statements)

References 100 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In this study, 33% of the patients reported lack of orgasms, 27% lack of libido, and 12% increased spasticity during their sexual activities (8). Another study reported that 40% of women affected by this disease stated that their sexual life had worsened after the diagnosis of their disease (15).…”

Section: One Of the Most Important Complications Of This Dis-mentioning

confidence: 51%

The Prevalence of Sexual Dysfunction in Iranian Women with Multiple

et al. 2019

View full text Add to dashboard Cite

Context: Sexual dysfunction is one of the most common symptoms in women with multiple sclerosis (MS), which has a great impact on the individuals' quality of life, and is usually neglected. The present study was conducted with the aim of studying the prevalence of sexual dysfunction in Iranian women with MS. Evidence Acquisition: All Iranian articles published between 2000 and June 2018 in Persian and English were collected by using standard keywords in national and international databases. After evaluating articles based on inclusion/ exclusion criteria and quality assessment, related articles were selected. Heterogeneity of the studies was evaluated using the I 2 index and the publication bias was assessed using the Egger and Begg tests. Data analysis was performed in STATA software version 11, 1 by using random effect model. Results: Eight studies with a sample size of 1,301 people entered in this meta-analysis. The overall prevalence of sexual dysfunction in women with MS was 62% (CI: 95%, 51%-73%). In addition, the prevalence of sexual dysfunction by using female sexual function index (FSFI) was 57% (CI: 95%, 46%-68%) and by using multiple sclerosis intimacy and sexuality questionnaire-19 (MSISQ-19), was 73% (CI: 95%, 55%-91%). Conclusions: The results of the present study were indicative of a prevalence of 62% for sexual dysfunction in Iranian women with MS. Considering the high prevalence of sexual dysfunction and its impact on the quality of life of these women, it seems essential for treatment teams to pay attention, plan, and design effective interventions in this regard.

show abstract

Section: One Of the Most Important Complications Of This Dis-mentioning

confidence: 51%

The Prevalence of Sexual Dysfunction in Iranian Women with Multiple

et al. 2019

View full text Add to dashboard Cite

show abstract

“…It could be argued that the treatment of sexual dysfunction in MS should be based on an assessment of sexual dysfunction and should target the specific problem of the patient. As shown in our scoping review, 23 sexual dysfunction in MS affects many psychological, neuropsychological, and social life domains. To reduce the burden on patients and their everyday life, psychobehavioral interventions should involve techniques such as compensatory strategies, using aids, supporting the patient's awareness, and counseling patients and their partners about how to manage their specific sexual dysfunction.…”

Section: Study Quality Assessmentmentioning

confidence: 89%

“…In contrast to the known prevalence of sexual dysfunction in MS, treatment options particularly for secondary and tertiary sexual dysfunction are rare, and drug treatment options for primary sexual dysfunction are not convincingly effective. 23 This updated systematic review included six studies and showed beneficial effects of psychobehavioral treatment approaches for sexual impairment and sexual satisfaction in people with MS. Unfortunately, the small number of intervention studies limits the interpretation of results, but, based on the findings of this review, psychobehavioral interventions seem to be effective in decreasing patient-reported sexual dysfunction in the short term (and up to 3 months).…”

Section: Discussionmentioning

confidence: 99%

“…23 So far, conventional disease-modifying therapies have not been specifically involved in the treatment of sexual dysfunction in MS. 24 Recent studies with disease-modifying drugs (natalizumab and interferon beta-1a) found positive and negative effects of MSrelated treatment on sexual dysfunction. 25,26 Based on the fact that drug treatment is not a panacea for sexual dysfunction in MS, 23 the focus of researchers has become increasingly targeted to nonpharmacologic approaches. Nonpharmacologic treatment options comprise psychological and behavioral interventions and approaches focusing on primary, secondary, and tertiary sexual dysfunction in MS.…”

Section: Study Quality Assessmentmentioning

confidence: 99%

See 1 more Smart Citation

Psychobehavioral Treatment Options for Sexual Dysfunction in Multiple Sclerosis

Pöttgen¹,

Vis²,

Nunen³

et al. 2020

International Journal of MS Care

View full text Add to dashboard Cite

Background: Sexual dysfunction in multiple sclerosis (MS) is a significant but overlooked impairment, and treatment options are rare. The aims of this systematic review were to identify psychological interventions used to treat sexual dysfunction in MS, to estimate their benefit, and to note appropriate treatment approaches for research projects and clinical use. Methods: A systematic review update was conducted to find psychological interventions aiming to improve sexual dysfunction in MS. A comprehensive search and review of MEDLINE, PsycINFO, CINAHL, and PubMed were completed, and the effects and quality of selected studies were reported. Results: Six publications with 295 participants were identified. All selected studies assessed the effectiveness of psychological interventions on sexual dysfunction or sexual satisfaction in people with MS; four studies directly targeted sexual dysfunction in MS, one was a mindfulness yoga program to improve fatigue and quality of life, and one other presented a secondary analysis of a study targeting depression in MS. All six studies reported significant improvements in sexual dysfunction or sexual satisfaction and somewhat in psychological variables. Conclusions: A pressing need for development and adequate evaluation of psychological interventions for sexual dysfunction in MS remains. In addition, assessment of sexual dysfunction in MS and its treatment should be more focused in clinical care.

show abstract

“…Kaže se kot zmanjšan ali celo odsoten libido, spremenjeni občutki v genitalijah ali parastezije ter zmanjšano število ali intenziteta orgazmov. Pri moških se pojavi erektilna disfunkcija, pri ženskah pa zmanjšana vaginalna vlažnost in zmanjšan tonus vaginalnih mišic (Lording, 2005;Sharon van Rey, 2005;Delaney & Donovan, 2017). Sekundarna spolna disfunkcija nastane zaradi drugih simptomov MS, ki nimajo neposrednega vpliva na spolno funkcijo.…”

Section: Uvodunclassified

Spolna disfunkcija pri slovenskih pacientih z multiplo sklerozo

2020

View full text Add to dashboard Cite

Uvod: Spolna disfunkcija je pri pacientih z multiplo sklerozo pogosta, ustreznih podatkov za slovensko populacijo pa ni na voljo. Namen raziskave je bil ugotoviti vrsto in delež spolne disfunkcije, razlike med moškimi in ženskami ter morebitno povezavo med spolno disfunkcijo in značilnostmi pacientov.Metode: Presečna raziskava je bila izvedena pri pacientih z multiplo sklerozo, ki so imeli spolne odnose v zadnjih šestih mesecih in so izpolnili vprašalnik MSISQ-19 (Multiple Sclerosis Intimacy and Sexuality Questionnaire). V raziskavi je sodelovalo 368 pacientov povprečne starosti 40,9 leta in trajanjem bolezni 10,2 leta. Nevrološko prizadetost smo ocenili z EDDS (Expanded Disability Status Scale). Za primerjavo številčnih spremenljivk smo uporabili neparni t-test, za primerjavo kategoričnih spremenljivk hi-kvadrat,povezanost med značilnostmi pacientov ter posamezno obliko spolne disfunkcije pa smo ocenili s pomočjo korelacijskega koeficienta po Spearmanu.Rezultati: Delež spolne disfunkcije, definiran kot odgovor 4 ali 5 na katero koli vprašanje v MSISQ-19, je znašal 37 %, deleži primarne, sekundarne in terciarne spolne disfunkcije pa 39,4 %, 39,9 % in 40,8 %. Med spoloma ni bilo statistično pomembnih razlik. Statistično značilno, a zelo šibko linearno korelacijo smo ugotovili med značilnostmi pacientov (starost, trajanje bolezni, EDSS, trajanje partnerske zveze) ter posamezno obliko spolne disfunkcije.Diskusija in zaključek: Spolno disfunkcijo ima 37 % slovenskih pacientov z multiplo sklerozo. Med spoloma ni statistično pomembnih razlik, kar velja tudi za posamezne vrste spolne disfunkcije, kot so primarna, sekundarna in terciarna.

show abstract

Multiple sclerosis and sexual dysfunction: A need for further education and interdisciplinary care

Cited by 39 publications

References 100 publications

The Prevalence of Sexual Dysfunction in Iranian Women with Multiple

The Prevalence of Sexual Dysfunction in Iranian Women with Multiple

Psychobehavioral Treatment Options for Sexual Dysfunction in Multiple Sclerosis

Spolna disfunkcija pri slovenskih pacientih z multiplo sklerozo

Contact Info

Product

Resources

About